CEPA’s Global Health practice contributes to the effectiveness and sustainability of development aid in the health sector. We combine public policy, health economics and evaluation expertise towards improving the quality and use of evidence for strategic, policy and programmatic planning and implementation.
We conduct short, medium and long- term assignments, with clients including global health partnerships, multi-lateral and bi-lateral agencies, donors and foundations, governments and international NGOs. We provide a unique offering of multi-sectoral expertise for global health, through our work in several development areas across CEPA’s other practices of agriculture, infrastructure and water.
Over the last 15 years, we have gained a wealth of knowledge and expertise across a number of health areas which we apply at both global and country levels. These include: communicable and non-communicable diseases; health and community systems strengthening; immunisation; maternal and child health, sexual and reproductive health; and nutrition. We also work in a number of cross-cutting areas such as health policy and governance, health financing, health data and information systems, commodity market dynamics, as well as universal health coverage. Together, our breadth of experience has given us the knowledge and skills to conduct complex evaluations and strategic reviews, and to provide high level technical advisory support. As applied economists, our main strength is bringing together diverse sources of evidence and analysis to develop relevant and nuanced conclusions and recommendations on complex issues.
To complement the skills of our internal team, CEPA has a wide network of expert associates and institutional partners worldwide, whom we draw upon for specific mandates.
Expertise specific to Global health
Evaluation and impact assessment
CEPA draws on its broad methodological expertise to provide evaluation services that are wide-ranging both technical and geographic scope.
Strategy and governance
CEPA provides broad organisational support relating to the design, development and review of programmes, policies, strategies and supportive systems.
CEPA provides a range of health economics services to our clients. These include economic and business cases, value for money assessments and cost benefit or cost effectiveness analyses for varied health interventions or services. We have also conducted reviews of health care consumption, as well as analyses of the functionality of healthcare systems and health-affecting behaviours.
Health policy and technical advisory
CEPA combines its expertise in synthesising available evidence from a range of sources with a solid understanding of health governance, strategic planning and policy processes at both global and country levels. CEPA provides technical advisory support and informs policy review processes across a range of global health areas.
CEPA provides flexible and versatile support to organisations and global health partnership secretariats when additional capacity is required.
Health data and information systems
CEPA has extensive experience in evaluating the design and implementation of data and information systems, as well as monitoring, evaluation and learning frameworks, at community, national and global levels.
Operational research and evidence synthesis
CEPA utilises a range of quantitative and qualitative methodologies to generate evidence and conduct operational research across a range of health areas. We are experts in effectively synthesising complex and nuanced evidence across numerous data sources.
Communicable & non-communicable diseases
We have comprehensive knowledge and expertise in communicable diseases, including HIV/AIDS,...
Health & community systems strengthening
Our team has substantial experience in the design, implementation and evaluation of...
Our team has extensive experience in immunisation systems strengthening and knowledge context...
Market dynamics, supply & access
CEPA has substantive experience in retrospective and prospective market dynamics analyses, including...
Sexual, reproductive, maternal, newborn, child & adolescent health
We have a strong understanding of the priorities and issues on the...
The key contacts for our Global health practice are...
To talk to someone about our experience in this sector, please call either +44 (0)20 7269 0210 for the UK, or +61 2 9006 1308 for Australia.View our entire Global health team
Global health News & insights
CEPA recognised as one of the UK’s leading management consultants
Following another year of providing high-quality advice to our clients across our core sectors, we are grateful for the positive feedback from the market, which has led to CEPA’s inclusion in the Financial Times’ independent ratings report.
CEPA modelling shows the economic and public health impact of voluntary licensing
Licences negotiated by the Medicines Patent Pool will save the international community an estimated USD 3.5bn and 170k lives by 2030. This is according to a new methodology for estimating the impact of licences that was validated via a peer-reviewed article published in The Lancet.
CEPA evaluates Unitaid’s investments in Hepatitis C
Unitaid has invested more than US$45 million since 2015 in support of improving access to care for hepatitis C. We are pleased to have provided them with a portfolio evaluation and end of grant evaluations.
Applying the ‘no-one worse off’ criterion
Laura Grobicki has contributed to an article published in the journal 'AIDS', related to the HIV allocative efficiency modelling work she undertook in Togo.
Evaluation of cooperation agreements between health organisations
The Global Fund commissioned CEPA to conduct an evaluation of its Cooperation Agreements with WHO and the Stop TB Partnership on the provision of technical assistance to support the development of country concept notes and grant-making.
Thematic review to assess an approach to investing in resilient & sustainable systems for health
CEPA conducted a thematic review to assess the Global Fund’s current approach to investments in Resilient and Sustainable Systems for Health (RSSH).
Evaluation of community, human rights and gender interventions
CEPA was appointed to develop an evaluation framework and methodology to help the Stop TB Partnership to evaluate its community, human rights and gender focused work.
Monitoring of Gavi Market Shaping Externalities
As part of its Supply and Procurement Strategy for 2016-2020, Gavi committed to monitor any negative and positive unintended consequences, so-called externalities, that could arise from its market shaping activity.
Evaluation of Gavi health system strengthening support to Nepal
Gavi commissioned an evaluation of its Health System Strengthening (HSS) support to Nepal through the pooled funding mechanism.
Modelling ROI on reproductive, maternal, newborn, child & adolescent health & nutrition interventions
CEPA conducted a modelling of the Global Financing Facility’s return on investment for Reproductive, Maternal, Newborn, Child and Adolescent Health and Nutrition (RMNCAH-N) interventions.
Making markets for children with HIV
Our evaluation of the impact of Unitaid's support for treating children living with HIV demonstrated the pivotal role the organisation had in creating a market for paediatric antiretroviral (ARV) medicine.
Framework for integration of disease programmes into health systems
CEPA was commissioned by the Global Fund to develop a framework and diagnostic tool for assessing governance-level bottlenecks to the integration of disease programmes into national health systems.
Mid-term evaluation of the Unitaid “Self-testing Africa (STAR)” project
CEPA was appointed to review the implementation of the first phase of Unitaid’s HIV self-testing grant to identify areas that worked well and those that worked less well, determine the extent to which the project achieved its intended impacts.
Advisory support to the Partnership for Maternal, Newborn and Child Health
CEPA was asked to carry out an analysis of the factors affecting provision of Overseas Development Assistance (ODA) for Sexual, Reproductive, Maternal, Newborn, Child and Adolescent related health programmes (SRMNCAH).
Review of the Global Task Force on Cholera Control
CEPA was appointed by the Global Task Force on Cholera Control (GTFCC) to conduct an independent review of the revitalised Task Force.
Evaluation of the ‘Improving Severe Malaria Outcomes’ project
CEPA was appointed to conduct a mid-term and an end-term review of Unitaid’s “Improving Severe Malaria Outcomes” project.
Development of Global Strategy for Womens’, Childrens’ & Adolescents’ Health
CEPA supported the PMNCH’s Consultation on the Global Financing Facility in conducting a global consultation process and producing a report.
Learning agenda – Gavi’s new country engagement framework
CEPA was appointed by Gavi to capture feedback and document lessons during the early implementation phase of Gavi’s new country engagement framework approach.
Development of Gavi application guidelines
CEPA was commissioned to develop Gavi’s Application Guidelines and Forms for 2016 and 2017.
Meta-review of Gavi health systems strengthening (HSS) country evaluations
CEPA conducted a meta-review of 14 country evaluations of Gavi HSS support in order to inform Gavi’s review of its HSS window of support.
Prospective evaluation design for the Bangladesh Home Fortification Project
CEPA supported CIF with an evaluation of the Bangladesh Home Fortification Project, aimed at reducing anaemia among young children.
Evaluation of the Stop TB Partnership
CEPA was appointed to undertake a Value for Money (VfM) evaluation of the Stop TB Partnership covering the period 2007 to 2013.
Innovative financing mechanisms for malaria elimination
CEPA was appointed to review current financing trends for malaria eliminating countries and consider suitable innovative financing mechanisms that could be developed to support malaria elimination.
Review of Unitaid’s Medicines Patent Pool (MPP)
CEPA undertook a review to closely assess the strategic direction, positioning and operations of the MPP.
Evaluation of the Norway India Partnership Initiative
CEPA was appointed by the Evaluation Department at Norad to conduct a process evaluation of the Norway India Partnership Initiative (NIPI) with the aim to reduce child and maternal mortality.
Investment case for Civil Registration and Vital Statistics
The purpose of the assignment was to prepare an investment case for Civil Registration and Vital Statistics (CRVS) systems, to serve as a key advocacy document to garner support for and investment in, CRVS systems.
Mid-term review of GAIN’s Infant and Young Child Nutrition programme
CEPA conducted a mid-term review of GAIN’s Infant and Young Child Nutrition programme.
Evaluation of Gavi Phase II
A consortium led by CEPA carried out the second evaluation of Gavi. The evaluation assessed Gavi’s performance since inception, focusing on the period between 2006 and 2009.
Market Dynamics Study on drugs and diagnostics for communicable diseases
CEPA was commissioned by the Global Fund to conduct a Market Dynamics Study focusing on seven product areas (drugs and diagnostics for the three disease areas, and Long-Lasting Insecticide-treated Nets).
Lessons and opportunities for the Global Fund to support the accelerated and equitable scale-up of innovations
We are conducting an evaluation, the findings and recommendations of which will inform the Global Fund's work to improve access to innovations under its new 2023-28 Strategy.
Helping Unitaid to explore the potential impact of future innovation in support of its strategy
We explored the potential impact of ten promising innovations that Unitaid may support during its 2023-27 strategic period, which could make a significant contribution to advancing global health targets.